Govt Job: For Pharmacology, Life Sciences Job as Editorial Assistant at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab, and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India, Pt. Jawahar Lal Nehru, who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Editorial Assistant (One Post)

Applications are invited on a plain paper for the contractual post of Editorial Assistant in International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN) by Professor Bikash Medhi, Chief Editor, Department of Pharmacology, PGIMER, Chandigarh-160012. The post is purely on temporary basis.

Qualification :First Class Master’s Degree in Pharmacology / Life-Sciences from a recognized university.

Desirable : Experience in the Research field or scientific writing. Candidates with proficiency in computer application will be preferred

Age : As per GOI rules
Pay Scale : Rs. 35, 000/- per month (consolidated).

The above appointment will be purely on temporary basis. Interested candidates fulfilling the above conditions are required to submit their bio-data and necessary testimonials/ certificates by 6th May, 2022, through email at recruitmentmanpowereplpgimer@gmail.com

The candidates will be scrutinized by the selection committee and only short-listed candidates will be intimated through email/phone to attend the interview through online mode. No Separate interview letters will be sent.

Related Posts

  • Pharma
  • July 11, 2025
  • 94 views
India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

July:  India’s Glenmark Pharmaceuticals (GLEN.NS), opens new tab said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie (ABBV.N), opens new tab have signed an exclusive licensing agreement…

  • Pharma
  • July 10, 2025
  • 155 views
Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Novartis wins approval for first malaria drug for newborns and babies

Novartis wins approval for first malaria drug for newborns and babies